Managing Chronic Kidney Disease (CKD)
in Type 2 Diabetes
Focus on MRAs — Expert insights from our multidisciplinary, pan-Canadian panel on screening, guidelines, residual risk, and novel treatments
About This Program
Hear what our multidisciplinary, pan-Canadian expert panel has to say about chronic kidney disease (CKD) in patients with type 2 diabetes (T2D) in the Hallway Huddle. Each 5–10-minute video in this series features one of our experts presenting the latest on screening, guidelines, residual risk, and novel treatments for the management of CKD in T2D.
French Version AvailableLearning Objectives
Access Program Content
Choose how you'd like to explore CKD management in T2D — watch expert videos or ask our AI assistant
Ask Our AI Assistant
Get instant, personalized answers about CKD management, MRA therapy, and guideline recommendations. Our AI assistant is trained on all program content including expert videos and clinical guidelines.
Expert Video Library
Browse our collection of expert presentations on key topics
When and why should patients with T2D have their UACR tested?
What do the guidelines say about managing CKD in T2D?
What are the key differences between steroidal MRAs and nonsteroidal MRAs?
For which patients should novel nonsteroidal MRAs be considered?
What data supports the use of novel nonsteroidal MRAs in patients already on an SGLT2 inhibitor?
When and how should potassium levels be monitored and managed in patients on MRAs?
What is residual risk and why does it matter in patients with CKD and T2D?
Measures of albuminuria and why UACR is the gold standard for measuring cardiorenal risk
What are the MOAs of the new therapies and how do they complement each other?
What to know about initiating and monitoring patients on finerenone?
What to tell patients about adding another treatment, like finerenone to their regimen?
What are the highlights from the 2025 Diabetes Canada CKD in Diabetes Guidelines? NEW
Expert Faculty
Our multidisciplinary panel of Canadian healthcare professionals
Associate Professor, University of Toronto
Toronto, ON
Membre du comité national trajectoire en diabète
Membre du comité national trajectoire en obésité
Chargé de cours formation en médecine IPSA UL
Québec (Québec)
Nephrologist, London Health Sciences Centre
Deputy Chair, Division of Nephrology
Schulich School of Medicine & Dentistry, Western University
London, ON
Medical Director, Chronic Disease Management
Calgary, AB
Centre Hospitalier de l'Université de Montréal
Montreal, QC
Assistant Professor, McGill University
Montreal, QC
Professor of Medicine, University of Manitoba
Winnipeg, MB
Assistant Professor, University of Toronto
Toronto, ON
Professor of Medicine, University of Manitoba
Winnipeg, MB
Associate Professor, University of Toronto
Toronto, ON
